Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193382 | SCV000247679 | uncertain significance | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000193382 | SCV000334784 | likely benign | not specified | 2015-10-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000471444 | SCV000524869 | likely benign | not provided | 2021-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080555 | SCV000563634 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311297 | SCV000846325 | likely benign | Inborn genetic diseases | 2021-07-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institute for Genomic Medicine |
RCV000193382 | SCV000864308 | likely benign | not specified | 2017-04-28 | criteria provided, single submitter | clinical testing | BS1,BP4,BP6; This alteration has an allele frequency that is greater than expected for the associated disease, is predicted to be tolerated by multiple functional prediction tools, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
Athena Diagnostics | RCV000471444 | SCV001144346 | benign | not provided | 2019-06-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000471444 | SCV004010897 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | KCNT1: BP4, BS1 |
Bioinformatics Core, |
RCV000656028 | SCV000588304 | pathogenic | Childhood epilepsy with centrotemporal spikes | 2017-01-01 | no assertion criteria provided | case-control | CAADphred>15 |
Prevention |
RCV003917754 | SCV004728425 | likely benign | KCNT1-related disorder | 2020-07-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |